2003
DOI: 10.1016/s1053-2498(02)00477-1
|View full text |Cite
|
Sign up to set email alerts
|

Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

9
255
1
18

Year Published

2010
2010
2021
2021

Publication Types

Select...
4
2
2

Relationship

0
8

Authors

Journals

citations
Cited by 264 publications
(283 citation statements)
references
References 33 publications
9
255
1
18
Order By: Relevance
“…7,8 As shown in Figure 2, the patient had multiple nodular lesions, especially in the right upper lobe.…”
Section: Discussionmentioning
confidence: 97%
“…7,8 As shown in Figure 2, the patient had multiple nodular lesions, especially in the right upper lobe.…”
Section: Discussionmentioning
confidence: 97%
“…Most Aspergillus infections historically occurred within the first year following SOT [20,73,74]. Tracheobronchial and/or anastomotic Aspergillus infections typically occurred within the first 90 days post transplant compared with invasive pulmonary aspergillosis which tended to occur later [73,74].…”
Section: Ifi Timeline: Sotmentioning
confidence: 99%
“…Tracheobronchial and/or anastomotic Aspergillus infections typically occurred within the first 90 days post transplant compared with invasive pulmonary aspergillosis which tended to occur later [73,74]. The majority of experts agree that the risk for IA is substantially high enough immediately following lung transplant to warrant antifungal prophylaxis and American Society of Transplantation guidelines recommend continuing prophylaxis following lung transplantation at least until bronchial anastomosis remodeling is complete [75].…”
Section: Ifi Timeline: Sotmentioning
confidence: 99%
See 1 more Smart Citation
“…Aspergillus, also the commonest affecting 6.2% of all lung transplant recipients (Singh and Husain 2003), may take the form of tracheobronchitis, anastomotic infection of parenchymal invasion, although disseminated disease can also occur. Complicated surgery in addition to immunosuppressive therapy and renal impairment are recognized as risk factors for fungal infection, suggesting that extra vigilance may be warranted in Sarcoidosis patients in the weeks post procedure.…”
Section: Infectionsmentioning
confidence: 99%